Profil
Prior to joining New Hill, Dr. Amara was principal at East Hill portfolio, working closely with the companies on business plans and implementation.
Dr. Amara has over wealth of experience in the biotech industry, in research and development and business roles.
From 2000 to 2005, she negotiated R&D business development transactions at Biogen Idec.
Previously, she had research, project management and licensing responsibilities at start-up and established biotechnology companies, including Genzyme and ARIAD Pharmaceuticals.
Dr. Amara received a BA in Biology, cum laude and Phi Beta Kappa, from the University of California, San Diego, and a PhD in Pharmacology from Yale University, and was a postdoctoral fellow in the lab of Professor Harvey Lodish at the Whitehead Institute.
During her research career Jane published nineteen scientific papers in areas of cancer, cellular biology, protein processing and gene therapy.
Anciens postes connus de Jane F. Amara
| Sociétés | Poste | Fin |
|---|---|---|
New Hill Management LLC
 New Hill Management LLC Investment ManagersFinance New Hill Management LLC(New Hill Management) is a venture capital firm founded in 2001 by Jeffrey S.Garner. The firm Headquartered in Boston, US. | Private Equity Investor | 01/10/2012 |
East Hill Management Co. LLC
 East Hill Management Co. LLC Investment ManagersFinance East Hill Management Co. LLC (East Hill Management) is a venture capital firm founded in 2000 by Landon Thomas Clay and Jeffrey Scott Garner. The firm is headquartered in Providence, Rhode Island. | Analyste en capital-investissement | 01/09/2007 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/12/2004 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/1999 |
Formation de Jane F. Amara
| Yale University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
East Hill Management Co. LLC
East Hill Management Co. LLC Investment ManagersFinance East Hill Management Co. LLC (East Hill Management) is a venture capital firm founded in 2000 by Landon Thomas Clay and Jeffrey Scott Garner. The firm is headquartered in Providence, Rhode Island. | Finance |
New Hill Management LLC
New Hill Management LLC Investment ManagersFinance New Hill Management LLC(New Hill Management) is a venture capital firm founded in 2001 by Jeffrey S.Garner. The firm Headquartered in Boston, US. | Finance |
